soul trial oral semaglutide cardiovascular outcomes 2025 The (Semaglutide Trial) was a randomized, double-blind, placebo-controlled cardiovascular outcomes trial that enrolled 9,650 patients aged 50 years or older with Oral Semaglutide Reduces CV Events
Description
Find someone to talk to
These medications help with controlling obesity, reducing hunger, and balancing blood sugar levels
Pifferi for assisting with information related to the RESTRIKAL study
Nausea on semaglutide usually stems from eating too quickly, eating high-fat or high-sugar foods, or taking the medication on a full stomach
Amy Killen, a renowned physician specializing in longevity and regenerative medicine
